EyePoint Pharmaceuticals Q3 EPS $(1.07) Misses $(0.91) Estimate, Sales $756.000K Beat $223.077K Estimate
Benzinga Newsdesk 1 hour ago
NewsEarningsEarnings BeatsEarnings Misses
EyePoint Pharmaceuticals (NASDAQ:EYPT) reported quarterly losses of $(1.07) per share which missed the analyst consensus estimate of $(0.91) by 17.58 percent. This is a 25.88 percent decrease over losses of $(0.85) per
EyePoint Pharmaceuticals (NASDAQ:EYPT) reported quarterly losses of $(1.07) per share which missed the analyst consensus estimate of $(0.91) by 17.58 percent. This is a 25.88 percent decrease over losses of $(0.85) per share from the same period last year. The company reported quarterly sales of $756.000 thousand which beat the analyst consensus estimate of $223.077 thousand by 238.90 percent. This is a 21.74 percent decrease over sales of $966.000 thousand the same period last year.